Search

Author/Creator Engelhard, Victor H

2. MHC-restricted phosphopeptide antigens: preclinical validation and first-in-humans clinical trial in participants with high-risk melanoma. Issue 1 (7th May 2020)

Authors:
Engelhard, Victor H; Obeng, Rebecca C; Cummings, Kara L; Petroni, Gina R; Ambakhutwala, Angela L; Chianese-Bullock, Kimberly A; Smith, Kelly T; Lulu, Amanda; Varhegyi, Nikole; Smolkin, Mark E; Myers, Paisley; Mahoney, Keira E; Shabanowitz, Jeffrey; Buettner, Nico; Hall, Emily H; Haden, Kathleen; ...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Tertiary lymphoid structures in desmoplastic melanoma have increased lymphocyte density, lymphocyte proliferation, and immune cross talk with tumor when compared to non-desmoplastic melanomas. (31st December 2023)

Authors:
Edmonds, Nicole L.; Gradecki, Sarah E; Katyal, Priya; Lynch, Kevin T; Stowman, Anne M; Gru, Alejandro A; Engelhard, Victor H; Slingluff, Craig L; Mauldin, Ileana S.
Journal:
Oncoimmunology
Issue:
Volume 12:Number 1(2023)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗